This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
| identifier | question |
|---|---|
| cord-001654-o2zfilcl | Do statins have a role in preventing or treating sepsis? |
| cord-001654-o2zfilcl | How will physicians respond to the next influenza pandemic? |
| cord-010773-z2eogm18 | Tisagenlecleucel in children and young adults with B- cell lymphoblastic leukemia Chimeric antigen receptor T cells for sustained remissions in leukemia FDA approval brings first gene therapy to the United States CAR- T-and a side order of IgG, to go? |
| cord-252305-rstxyofq | Can this product be delivered through multiple modalities to allow for flexibility( spray bottle with dry wipe packs vs. saturating wipe rolls in a A c c e p t e d M a n u s c r i p t 11 bucket, etc.)? |
| cord-252305-rstxyofq | Does the product have potential for toxicity or irritation? |
| cord-252305-rstxyofq | Does this product have an emerging viral pathogen claim? |
| cord-252305-rstxyofq | Is this product currently commercially available, and will it remain available for repurchase? |
| cord-252305-rstxyofq | Is this product economical for the healthcare institution? |
| cord-252305-rstxyofq | What is the method of delivery( pre- moistened wipe, spray, concentrate requiring dilution, etc.)? |
| cord-252305-rstxyofq | What is the pH of the product? |
| cord-252305-rstxyofq | What is the wet- contact time required to kill SARS- CoV-2? |
| cord-252305-rstxyofq | What surface types/ equipment is the disinfectant compatible with? |
| cord-256130-zhlvvuj4 | Are we there yet? |
| cord-256195-1hmzgwrw | Obesity: The"Achilles heel"for COVID-19? |
| cord-260257-phmd0u6d | On the front lines of coronavirus: the Italian response to covid-19 Self- testing for HIV: a new option for HIV prevention? |
| cord-260257-phmd0u6d | Proposed protocol to keep COVID-19 out of hospitals Self- Service Diagnosis of COVID-19-Ready for Prime Time? |
| cord-260257-phmd0u6d | The lancet HIV Self- Collected versus Clinician- Collected Sampling for Chlamydia and Gonorrhea Screening: A Systemic Review and Meta- Analysis Self- Service Diagnosis of COVID-19-Ready for Prime Time? |
| cord-260257-phmd0u6d | Virtually perfect? |
| cord-267023-w5ig7mrl | ( 1) Were antibiotics indicated for a"true infection"( no alternative noninfectious primary diagnosis)? |
| cord-267023-w5ig7mrl | ( 2) Did the"selected regimen"cover the infection and pathogens in question? |
| cord-267023-w5ig7mrl | ( 3) Were antibiotic"dose"and"duration"appropriate? |
| cord-267023-w5ig7mrl | : how are we educating our future prescribers? |
| cord-267023-w5ig7mrl | performance, education and knowledge Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship New societal approaches to empowering antibiotic stewardship CMS Issues Proposed Rule that Prohibits Discrimination, Reduces Hospital- Acquired Conditions, and Promotes Antibiotic Stewardship in Hospitals Health care provider education as a tool to enhance antibiotic stewardship practices Is there an app for that? |
| cord-282862-kve6fa49 | Overlapping Clinical Pictures in Two Gravid Patients Vaginal delivery in SARS- CoV-2-infected pregnant women in Northern Italy: a retrospective analysis Pre- labor anorectal swab for SARS- CoV-2 in COVID-19 pregnant patients: is it time to think about it? |
| cord-282862-kve6fa49 | Why are pregnant women susceptible to COVID-19? |
| cord-282862-kve6fa49 | pregnant women be included in phase IV clinical drug trials? |
| cord-310807-p5cb6idp | : what's new? |
| cord-303935-qdehf6rb | Do rhinoviruses reduce the probability of viral co- detection during acute respiratory tract infections? |
| cord-314517-n1yj2zdy | The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-310872-2z1wnj63 | Approximately 35 years after Dr. Petersdorf first asked the question, we find ourselves once again wondering, “ Whither Infectious Diseases? ” |
| cord-310872-2z1wnj63 | Are there data that support this assertion? |
| cord-310872-2z1wnj63 | How can the advantages ID experts bring be monetized to justify higher ID salaries? |
| cord-310872-2z1wnj63 | Indeed, ID practitioners are 1 of only 2 subspecialties remunerated below general internists in the United States[ 8], raising the obvious questionwhy should top talent choose to spend 2 or more additional years in training to end up making less money? |
| cord-310872-2z1wnj63 | Infectious diseases practitioners may be better at diagnosing and treating infections than those who practice other specialties, but to what financial advantage to healthcare systems that hang on by their fingernails with operating margins under 2%[ 16, 17]? |
| cord-310872-2z1wnj63 | Nearly a decade later, Dr. Petersdorf expanded on this theme in an incredibly prescient keynote lecture at the annual meeting of the Infectious Diseases Society of America titled,"Whither Infectious Diseases? |
| cord-310872-2z1wnj63 | So, even though I am an ID expert and love my clinical and research work, is it realistic to think that I can artificially inflate ID salaries at my hospital above the level the market will bear? |
| cord-310872-2z1wnj63 | The question is, how will our subspecialty evolve over time when our work and remuneration are in opposition to the predominant feefor- service market forces that govern US healthcare? |
| cord-310872-2z1wnj63 | These realities called out by Dr. Pedersdorf 34 years ago remain just as true today, leading us to again ask in 2020, whither infectious diseases? |
| cord-310872-2z1wnj63 | What has gone wrong? |
| cord-310872-2z1wnj63 | What is it that only ID practitioners do? |
| cord-310872-2z1wnj63 | Where is the ID in COVID-19? |
| cord-310872-2z1wnj63 | Whither infectious diseases? |
| cord-310872-2z1wnj63 | a nonprofit approach the future? |
| cord-350767-6kc4hyzo | Once- in- a- Century Pandemic? |